Antitrust
Viewpoints
Filter by:
FTC Warns AI Companies to Honor Privacy and Confidentiality Commitments — AI: The Washington Report
January 19, 2024 | Blog | By Michael Katz, Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
New Merger Enforcement Toolkit: FTC and DOJ Release Final 2023 Merger Guidelines
December 27, 2023 | Blog | By Bruce Sokler, Joseph Miller, Robert Kidwell, Payton Thornton, Matthew Tikhonovsky
Indecent Disclosure: FTC Slams Advertisers and Influencers for Failure to Divulge Material Connections
November 17, 2023 | Blog | By Bruce Sokler, Sherwet H. Witherington
Last June, the Federal Trade Commission (FTC) released its revised Endorsement Guides, the handbook for business practices that may be unfair or deceptive in violation of the FTC Act. The Endorsement Guides had been last revised in 2009 and the recent revisions sought to align practices with the ways advertisers reach consumers to promote products and services, including on social media.
Read more
FTC Follows Through on Promise to Roll Over Health Care Roll Ups
September 26, 2023 | Blog | By Bruce Sokler, Joseph Miller, Payton Thornton
Since the beginning of Chair Khan’s tenure at the Federal Trade Commission (and in line with President Biden’s aim to curb rising health care costs), the current FTC has committed to bring enforcement actions against health care consolidation and rising prices. Over the past two years the FTC has employed novel competition tools to achieve this purpose, as demonstrated by the Commission’s suit last week against a private equity firm and its related specialty practice—alleging violations of Sections 1 and 2 of the Sherman Act, Section 7 of the Clayton Act and Section 5 of the FTC Act.
Read more
The FTC "Settles" For a Conduct Consent Decree to Resolve Its Challenge to the Amgen-Horizon Merger
September 5, 2023 | Blog | By Bruce Sokler, Joseph Miller, Payton Thornton
The National AI Research Resource and the CREATE AI Act — AI: The Washington Report
August 4, 2023 | Blog | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Read about Representative Anna Eshoo’s (D-CA-16) CREATE AI Act, and the National Artificial Intelligence Research Resource that this bill would establish.
Read more
In with the Old, Out with the New: DOJ and FTC Issue Much-Anticipated Draft Merger Guidelines
July 26, 2023 | Blog | By Bruce Sokler, Joseph Miller, Robert Kidwell, Farrah Short, Evelyn French, Sherwet H. Witherington, Payton Thornton
Judge Denies FTC’s Motion for Preliminary Injunction in Microsoft’s Acquisition of Activision
July 12, 2023 | Blog | By Bruce Sokler, Payton Thornton
Proposed Overhaul of HSR Premerger Notification Process
June 28, 2023 | Blog | By Farrah Short, Bruce Sokler, Joseph Miller, Robert Kidwell
FTC and DOJ Antitrust Memorialize Joint Workshop on the Future of Antitrust Enforcement in the Pharmaceutical Industry
June 6, 2023 | Blog | By Bruce Sokler, Joseph Miller, Robert Kidwell, Payton Thornton
FTC Sends Notice of Potential Penalties to Approximately 670 Companies Regarding Substantiation of Advertising Claims
April 13, 2023 | Blog | By Bruce Sokler, Joanne Hawana, Robert Kidwell, Benjamin Zegarelli
Unanimous Federal Trade Commission Orders Illumina, Inc. to Divest GRAIL, Inc.
April 5, 2023 | Blog | By Bruce Sokler, Payton Thornton
DOJ Antitrust Division Announces Indictment Against Health Care Staffing Executive For Nurse Wage-Fixing
March 16, 2023 | Blog | By Bruce Sokler, Payton Thornton
Federal Trade Commission Continues Policy Initiatives by Seeking Public Comment on Franchisor-Franchisee Relationships
March 10, 2023 | Blog | By Bruce Sokler, Payton Thornton
DOJ Sues Google for Monopolizing Digital Advertising Markets
February 22, 2023 | Blog | By Joseph Miller, Tinny Song
Federal Judge Allows Antitrust Claims to Proceed Against Hospital System and Vertically-Integrated Physician Group
February 21, 2023 | Blog | By Bruce Sokler, Joseph Miller, Payton Thornton
Out with the Old: The Antitrust Division Withdraws Healthcare Enforcement Policy Statements
February 7, 2023 | Blog | By Bruce Sokler, Joseph Miller, Payton Thornton
Is Antitrust ESG's Achilles Heel ? House Republicans Think So.
December 13, 2022 | Blog | By Bruce Sokler, Jacob Hupart, Tinny Song, Payton Thornton
On the Board: DOJ Gets First Win in Criminal No-Poach Prosecution
October 31, 2022 | Blog | By Bruce Sokler, Tinny Song, Payton Thornton
DOJ Makes Good on Promise to Review Interlocking Directorates
October 21, 2022 | Blog | By Bruce Sokler, Robert Kidwell, Payton Thornton
The Department of Justice Antitrust Division (“DOJ”) recently announced that it has required several directors to resign from simultaneously serving on the corporate boards of competitor companies.
Read more
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology